204 related articles for article (PubMed ID: 3102810)
21. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer.
Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F
Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196
[TBL] [Abstract][Full Text] [Related]
22. [A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil].
Tashiro K; Kondo N; Ikemoto I
Hinyokika Kiyo; 1986 Mar; 32(3):449-53. PubMed ID: 3728246
[TBL] [Abstract][Full Text] [Related]
23. Cerebral metastases secondary to ovarian cancer: still an unusual event.
Bruzzone M; Campora E; Chiara S; Giudici S; Merlini L; Simoni C; Mammoliti S; Rubagotti A; Rosso R
Gynecol Oncol; 1993 Apr; 49(1):37-40. PubMed ID: 8482558
[TBL] [Abstract][Full Text] [Related]
24. [Chemotherapy of ovarian tumors using cis-platin].
Laurová L; Kobilková J; Novotná J; Motlík K; Fricová M; Hornický J
Cesk Gynekol; 1987 Feb; 52(1):41-4. PubMed ID: 3568161
[No Abstract] [Full Text] [Related]
25. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
26. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.
Fortin D; Gendron C; Boudrias M; Garant MP
Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866
[TBL] [Abstract][Full Text] [Related]
27. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
Ardizzoni A; Pronzato P; Conte PF; Rosso R
Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
[TBL] [Abstract][Full Text] [Related]
28. [A case of breast cancer metastasis to the skin and bone 13 years after, and to the brain 17 years after mastectomy].
Itoshima T; Yamamoto T; Kasamatsu T; Fujino H; Yamamoto H; Morita Y; Kodama M
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1331-3. PubMed ID: 9279355
[TBL] [Abstract][Full Text] [Related]
29. [Tumor chemotherapy of ovarian cancer patients in advanced age].
Behling H; Schirmer A; Krafft W; Brückmann D
Zentralbl Gynakol; 1988; 110(2):95-101. PubMed ID: 3364065
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
31. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
32. Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.
Franciosi V; Cocconi G; Michiara M; Di Costanzo F; Fosser V; Tonato M; Carlini P; Boni C; Di Sarra S
Cancer; 1999 Apr; 85(7):1599-605. PubMed ID: 10193952
[TBL] [Abstract][Full Text] [Related]
33. [Clinical trial of cisplatin in the treatment of ovarian carcinoma].
Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T
Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112
[TBL] [Abstract][Full Text] [Related]
34. [Preoperative chemotherapy for advanced breast cancer].
Shiba E; Nishizawa Y; Koyama H; Terasawa T
Gan To Kagaku Ryoho; 1985 May; 12(5):1003-9. PubMed ID: 3922305
[TBL] [Abstract][Full Text] [Related]
35. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
[TBL] [Abstract][Full Text] [Related]
36. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
Wu BZ
Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
[No Abstract] [Full Text] [Related]
38. [Polymer-drug complexes in the treatment of extensive ovarian cancer].
Novikova EG; Borisov VI; Dmitriev DG; Zel'vin BM; Karseladze AI; Shchitkov KG; Li AD
Sov Med; 1991; (11):27-9. PubMed ID: 1767307
[TBL] [Abstract][Full Text] [Related]
39. [Predictive value of P53 expression in selecting first-line chemotherapy regimen for advanced epithelial ovarian carcinoma].
Zhao XD; Zhang Y; He SR; Yang L
Ai Zheng; 2005 Dec; 24(12):1542-5. PubMed ID: 16351810
[TBL] [Abstract][Full Text] [Related]
40. [A case report of ovarian cancer stage Ia with micrometastasis of para-aortic lymph node].
Adachi S; Noda T; Hirano Y; Katou Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Nov; 44(11):1459-62. PubMed ID: 1460366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
